Nicholas A. Nelson
CIK: 0001857944
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NAUT
Nautilus Biotechnology, Inc.
Officer
Discretionary Trading P&L
Holdings
About Nelson Nicholas A.
Nelson Nicholas A. (SEC CIK 0001857944) files insider reports with the SEC as CBO & Senior VP, Bus. Dev. of Nautilus Biotechnology, Inc. (NAUT).
Signal8 holds 1 ownership filing by Nelson Nicholas A., a Form 4, filed on Mar 4, 2025. Those filings report 1 transaction, the latest on Mar 3, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Nelson Nicholas A.'s filings is in SEATTLE, WA.
Recent filings by Nelson Nicholas A.
- Mar 3, 2025: Grant or award of NAUT derivative securities (Form 4, code A).
Other insiders filing for Nautilus Biotechnology, Inc. (NAUT)
- Posard Matthew L., Director
- NAZEM FARZAD, Director
- Akinsanya Karen, Director
- McIlwain Matthew S, Director
- Epperly Melissa B,, Director
- AH Equity Partners Bio II, L.L.C., 10% Owner